Regarding the pro-angiogenic and lymphangiogenic roles of NOX1 and ADAM17 in CRC, we hypothesized that sMCAM could act as a lymphangiogenic growth factor and promote tumor lymphangiogenesis. Here, ADAM17 is linked to neoplasm.